Application Types

Last Updated on February 22, 2022

Drug Product Registration Application Types

Registration Board of DRAP under Section 7 of the Drugs Act, 1976 registers drugs (pharmaceuticals and biologicals) for human or veterinary use. Divisions of Pharmaceutical Evaluation & Registration and Biological Evaluation & Research of DRAP receive various types of applications for drug product registration as explained below. It is a pre-requisite to have a Drug Manufacturing License (DML) for manufacturers or Drug Sales License (DSL) for importers to apply for any of the following types of drug product registration.

Visual representation of types of applications for registration of a pharmaceutical or biological drug
Forms required for application

Following are the regulatory forms required for applying for various type of drug product registration for human use:

S.NoDetailsApplication Form
1New Drug / Molecule (local manufacture / import)Form 5 F
2Any other Drug for ImportForm 5 F
3Locally manufactured drug with imported source of Half-Finished Products (Ready to Fill Bulk i.e., Pellets, Granules, etc)Form 5 F
4Generic Drugs (local manufacture)Form 5 F
5Drugs for Export PurposeFrom 5 / 5A / 5D)
6Drugs for export purpose on contract manufacturing basis.Form 5
7Drugs for Export Purpose; where no generic product is available.Form 5 D
8Grant / extension of contract manufacturing permissionForm 5 F
Requirements of Form 5 F (Common Technical Document)

Mandatory form for submission of registration application is Form 5 F. The requirements of Data submission on Form 5 F (Common Technical Document) under SRO 713(I)/2018 dated 08 June 2018 for registration of a pharmaceutical drug for human use are as follows:

CategoryModule 1Module 2Module 3Module 4Module 5
New Drug ProductYes YesYesYesYes
Generic Drug ProductYes  Yes
Optional: 2.3.S.2.2 2.3.S.2.3 2.3.S.2.4 2.3.S.2.5 2.3.S.2.6 2.3.S.7.2
Yes
Optional: 3.2.S.2.2 3.2.S.2.3 3.2.S.2.4 3.2.S.2.5 3.2.S.2.6 3.2.S.7.2 3.2.R.3
Yes
Optional for approved drug products in the same combination, strength, and dosage form by reference regulatory authorities adapted by Registration Board.  
Yes
Optional for approved drug products in the same combination, strength, and dosage form by reference regulatory authorities adapted by Registration Board.  
Guidelines

Guidance document for submission of application on Form 5 F (CTD) for registration of drugs